Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 09.11.2026 1 Acta Ophthalmol 1 Am J Kidney Dis 1 Ann Intern Med 4 BMC Ophthalmol 1 Br J Ophthalmol 8 Diabet Med 1 Diabetes Care 26 Diabetes Obes Metab 3 Diabetologia 1 Invest Ophthalmol Vis Sci 1 J Clin Endocrinol Metab 1 J Clin Invest 1 J Diabetes Complications 1 J Hypertens 1 Metabolism 1 Nature 1 Ophthalmology 1 PLoS Med 9 PLoS One 1 Proc Natl Acad Sci U S A 1 WMJ

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. TORM MEW, Johannesen J, Christensen JL, Dahl VA, et al
   Retinal capillary density in relation to diabetes duration and levels of glycaemia in young patients with type 1 diabetes.
   Acta Ophthalmol. 2026 Oct 31. doi: 10.1111/aos.70255.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

2. SRIALLURI N, He JH, ScM JM, Oyeka CP, et al
   Sex Hormones and CKD Progression in Type 2 Diabetes: Look AHEAD Sex Hormone Study.
   Am J Kidney Dis. 2026 Oct 31:S0272-6386(26)01189.
   PubMed        
   
   

   
   Ann Intern Med

3. HALEY SP
   In adults with diabetes and risk for HF, an NT-proBNP-based screening strategy vs. usual care increased diagnostic yield for HF at 6 mo.
   Ann Intern Med. 2026 Nov 3. doi: 10.7326/ANNALS-26-04073.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

4. SU L, Zhu L, Dai H, Xu Q, et al
   A novel auxiliary method combining a smartphone with a handheld slit-lamp for ocular image documentation of cataracts and diabetic retinopathy in remote regions.
   BMC Ophthalmol. 2026;26:737.
   PubMed         Abstract available
   
   
5. NOONAN JE, Tezel TH
   Papillomacular bundle thickness is associated with visual acuity in proliferative diabetic retinopathy.
   BMC Ophthalmol. 2026;26:732.
   PubMed         Abstract available
   
   
6. XIONG X, Zhou Q, Cao Y, Tang M, et al
   TMT-based quantitative proteomic analysis of vitreous humor in proliferative diabetic retinopathy.
   BMC Ophthalmol. 2026;26:241.
   PubMed         Abstract available
   
   
7. OZDEMIR T, Erdogan G, Cebeci Z
   Prognostic value of OCT biomarkers and systemic factors for early and long term anatomical treatment response in diabetic macular edema.
   BMC Ophthalmol. 2026;26:721.
   PubMed         Abstract available
   
   

   
   Br J Ophthalmol

8. FENWICK EK, Piccoli G, Bucceri V, Tagliabue E, et al
   Quality of life impact in patients with centre-involving diabetic macular oedema undergoing intravitreal injections using a novel AI-driven computerised adaptive testing system.
   Br J Ophthalmol. 2026 Nov 4:bjo-2026-329721. doi: 10.1136/bjo-2026-329721.
   PubMed        
   
   

   
   Diabet Med

9. CANTLEY J, Logie L, Narendran P, Dayan C, et al
   Pancreatic beta-cell mitogenic regeneration in type 1 diabetes: A preclinical review.
   Diabet Med. 2026 Oct 30:e70484. doi: 10.1111/dme.70484.
   PubMed         Abstract available
   
   
10. LEE Y, Yoo H, Kim H, Kim DY, et al
    The evolving burden of type 2 diabetes mellitus in Asia, 1990-2023: A Global Burden of Disease Study 2023.
    Diabet Med. 2026 Oct 31:e70421. doi: 10.1111/dme.70421.
    PubMed         Abstract available
    
    
11. ZAIDI R, Mehta F, Kar P, Valabhji J, et al
    Implementation and Phase 1 evaluation outcomes of the NHS England National Diabetes Transition and Young Adult Pilot Programme (2022-2026).
    Diabet Med. 2026 Oct 31:e70521. doi: 10.1111/dme.70521.
    PubMed         Abstract available
    
    
12. ZHOU LY, Wu XB, Wang YQ, Hao Y, et al
    Impact of gestational diabetes mellitus and assisted reproductive technology on maternal and neonatal outcomes in twin pregnancies: A multicentre retrospective study in China.
    Diabet Med. 2026 Oct 31:e70512. doi: 10.1111/dme.70512.
    PubMed         Abstract available
    
    
13. ZHOU H, Miao G
    Liraglutide in type 1 diabetes: Cardiometabolic benefits and vascular risk assessment.
    Diabet Med. 2026 Oct 31:e70524. doi: 10.1111/dme.70524.
    PubMed        
    
    
14. NARENDRAN P, Tennant A, Cooper C, Campbell F, et al
    'Mindshifting' type 1 diabetes care: Preparing UK services for the era of disease-modifying therapy.
    Diabet Med. 2026 Oct 31:e70522. doi: 10.1111/dme.70522.
    PubMed        
    
    
15. WITOWSKA M, Margiotta-Casaluci L, Pantazis P, Dominguez-Villar M, et al
    Immune-competent organ-on-chip methodologies to study type 1 diabetes.
    Diabet Med. 2026 Nov 5:e70495. doi: 10.1111/dme.70495.
    PubMed         Abstract available
    
    
16. SURENDRAN A, Byrne M, Morrissey E, Alvarez-Iglesias A, et al
    Evaluating the effectiveness of the D1 Now intervention to improve outcomes among young adults with type 1 diabetes: Protocol for a cluster randomised controlled trial.
    Diabet Med. 2026 Nov 5:e70443. doi: 10.1111/dme.70443.
    PubMed         Abstract available
    
    

    
    Diabetes Care

17. HALL M, Penno MAS, Spelman T, Bacher R, et al
    Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study.
    Diabetes Care. 2026 Nov 2:dc261627. doi: 10.2337/dc26-1627.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

18. BURGHERR A, Tan ESW, Jacobi A, Pilgrim T, et al
    QTc Prolongation and the Sympathoadrenal Response to Hypoglycaemia in Diabetes: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026 Nov 2. doi: 10.1111/dom.71499.
    PubMed         Abstract available
    
    
19. HUANG CH, Wu JL, Ling TC, Yang AS, et al
    Real-World Comparison of Cardiorenal Outcomes With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Nov 2. doi: 10.1111/dom.71506.
    PubMed         Abstract available
    
    
20. PATOULIAS D, Karakasis P, Koufakis T
    Renal Effects of Dual GLP-1/Glucagon Receptor Agonism: How Should We SYNCHRONIZE With Emerging Evidence in Type 2 Diabetes and Obesity?
    Diabetes Obes Metab. 2026 Nov 2. doi: 10.1111/dom.71507.
    PubMed        
    
    
21. CHENG W, Liu W, Wei J, Zeng C, et al
    Genetically Proxied GIP-GIPR Pathway Perturbation and Fracture Risk.
    Diabetes Obes Metab. 2026;28:11839-11850.
    PubMed         Abstract available
    
    
22. SALIM H, Qureshi S, Gulsin GS, Khan HR, et al
    Effectiveness of Adding GLP-1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study.
    Diabetes Obes Metab. 2026;28:11755-11764.
    PubMed         Abstract available
    
    
23. SUN H, Xin X, Yan J, Huang T, et al
    Comparative Risk of Nonarteritic Anterior Ischemic Optic Neuropathy Among Glucagon-Like Peptide-1 Receptor Agonists: An Integrated Safety and Mechanistic Analysis.
    Diabetes Obes Metab. 2026;28:11689-11701.
    PubMed         Abstract available
    
    
24. LIU X, Wang W
    Real-World Adverse Event Reporting Patterns of Tirzepatide Versus Semaglutide: A Stratified Study of General and Healthcare Professional Cohorts in FAERS.
    Diabetes Obes Metab. 2026;28:11721-11734.
    PubMed         Abstract available
    
    
25. JOUBERT M, Amouyal C, Bismuth E, Borot S, et al
    Rethinking Meal Management in Automated Insulin Delivery: From Carbohydrate Counting to Simplified Approaches.
    Diabetes Obes Metab. 2026;28:11042-11049.
    PubMed         Abstract available
    
    
26. DI MOLFETTA S, Haxhi J, Franco F, Papa G, et al
    Practical Guidance for the Use of Control-IQ Technology During Physical Activity and Exercise.
    Diabetes Obes Metab. 2026;28:11032-11041.
    PubMed         Abstract available
    
    
27. HUANG B, Ma P, Wang W
    Fracture-Centred Skeletal Reporting Profiles of Glucose-Lowering Drug Classes in FAERS and JADER: Cross-Database and Regional Reporting-Context Analyses.
    Diabetes Obes Metab. 2026;28:11310-11319.
    PubMed         Abstract available
    
    
28. LIU Y, Yu L, Zhu D, Li Z, et al
    OGTT-Derived beta-Cell Function-Based Stratification of 2-Year Glycaemic Transitions in Chinese Adults With Prediabetes.
    Diabetes Obes Metab. 2026;28:11297-11309.
    PubMed         Abstract available
    
    
29. MAKINSON CH, Park J, Feldman EL, Callaghan BC, et al
    Longitudinal Metabolic Risk Factors Are Associated With Microvascular Complications.
    Diabetes Obes Metab. 2026;28:11328-11342.
    PubMed         Abstract available
    
    
30. STEFANSKA C, Chung R, Ramjaun S, Jin D, et al
    The SGLT2i Treatment Gap in UK Primary Care: A Cross-Sectional RWE Study of Prescribing in Clinical Practice.
    Diabetes Obes Metab. 2026;28:11278-11287.
    PubMed         Abstract available
    
    
31. NIU B, Xia MH, Wu JX, Deng FY, et al
    Genome-Wide Association Analyses Identify Distinct Genetic Architectures for Extreme Early-Onset and Late-Onset T2D.
    Diabetes Obes Metab. 2026;28:11132-11142.
    PubMed         Abstract available
    
    
32. YANG GP, Liu YX, Xie JL, Zeng S, et al
    Safety, Pharmacokinetics and Pharmacodynamics of the GLP-1/GIP/GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo-Controlled Phase 1a/1b Study.
    Diabetes Obes Metab. 2026;28:11217-11229.
    PubMed         Abstract available
    
    
33. SZTANEK F, Lorincz H, Harangi M, Nagy AC, et al
    Incretin-Based Therapies as Cardiometabolic Interventions: Outcome Hierarchy, Receptor-Network Pharmacology and Phenotype-Based Clinical Positioning.
    Diabetes Obes Metab. 2026;28:10977-10991.
    PubMed         Abstract available
    
    
34. ANAGNOSTOPOULOU V, Travlos CK, Marinho LL, Mavrakanas TA, et al
    Therapies for Cardiovascular-Kidney-Liver-Metabolic Syndrome: Reappraisal of Fibrates.
    Diabetes Obes Metab. 2026;28:10931-10949.
    PubMed         Abstract available
    
    
35. TANG H, Zhang B, Lu Y, Lu Y, et al
    Semaglutide, Tirzepatide and Clinically Recorded Alcohol-Related Outcomes in Type 2 Diabetes: A Target Trial Emulation.
    Diabetes Obes Metab. 2026 Nov 3. doi: 10.1111/dom.71470.
    PubMed         Abstract available
    
    
36. GREENFIELD JR, Frampton R, Snaith JR
    Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: The Importance of Identifying the Insulin-Resistant Type 1 Diabetes Phenotype, and Differentiating Early and Newer Generation Therapies.
    Diabetes Obes Metab. 2026 Nov 3. doi: 10.1111/dom.71505.
    PubMed        
    
    
37. 
    Correction to 'Gold and Clarke Questionnaires Identify Different People With Insulin-Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo-METRICS Study'.
    Diabetes Obes Metab. 2026 Nov 3. doi: 10.1111/dom.71508.
    PubMed        
    
    
38. PARK IR, Moon JS, Ha J, Ko E, et al
    beta-Cell Recovery Patterns With Initial Combination Versus Stepwise Therapy in Newly Diagnosed Type 2 Diabetes: TRIPLE-AXEL Post Hoc Analysis.
    Diabetes Obes Metab. 2026 Nov 3. doi: 10.1111/dom.71516.
    PubMed         Abstract available
    
    
39. DU F, Cicali B, Singh Ospina NM, Ruzieh M, et al
    Bleeding and Thromboembolic Outcomes Following GLP-1 Receptor Agonist Initiation in Patients With Type 2 Diabetes and Atrial Fibrillation Receiving Direct Oral Anticoagulants: A Target Trial Emulation.
    Diabetes Obes Metab. 2026 Nov 3. doi: 10.1111/dom.71481.
    PubMed         Abstract available
    
    
40. MARHEFKOVA N, Mikusova V, Roland R, Pazdernik M, et al
    Sleep Architecture, Glucose Regulation and Subclinical Cardiovascular Risk in Adults With Type 1 Diabetes Mellitus: A Wearable Sleep Tracking and Continuous Glucose Monitoring Study.
    Diabetes Obes Metab. 2026 Nov 3. doi: 10.1111/dom.71509.
    PubMed         Abstract available
    
    
41. 
    Correction to 'Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis'.
    Diabetes Obes Metab. 2026 Nov 3. doi: 10.1111/dom.71524.
    PubMed        
    
    
42. HOSSAIN MA, Agyei D, Brennan C, Kebede B, et al
    Can a Single Maximally Fortified Food Improve Glycaemia in Type 2 Diabetes? Randomised Crossover Trial of High-Fibre High-Protein Bread.
    Diabetes Obes Metab. 2026 Nov 4. doi: 10.1111/dom.71523.
    PubMed         Abstract available
    
    
43. DOZIER ZB, Wang LC, Ji Y, Anzalone AJ, et al
    Metformin and Severe Post-COVID-19 Outcomes Among Individuals With Diabetes Mellitus.
    Diabetes Obes Metab. 2026 Nov 5. doi: 10.1111/dom.71502.
    PubMed         Abstract available
    
    

    
    Diabetologia

44. SINGH NM, Wigmann C, Kress S, Zaharia OP, et al
    Associations of long-term exposure to air pollution with glucose homeostasis biomarkers and diabetes-related comorbidities in people with recent-onset type 1 and type 2 diabetes.
    Diabetologia. 2026 Nov 5. doi: 10.1007/s00125-026-06908.
    PubMed         Abstract available
    
    
45. MISRA S, Cigler M, El-Hakouni O, Vettoretti M, et al
    Real-world evidence for decisions in diabetes.
    Diabetologia. 2026 Nov 5. doi: 10.1007/s00125-026-06896.
    PubMed         Abstract available
    
    
46. ROIKJER J, Kvist AV, Leutscher PDC, Ejskjaer N, et al
    Gout as a risk factor for lower-extremity amputation in diabetes: a nationwide, register-based case-control study.
    Diabetologia. 2026 Nov 3. doi: 10.1007/s00125-026-06920.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

47. CAO K, Luo S, Xiang X, Zhao Q, et al
    Visual Perceptual Learning Based on Adaptive Contrast Detection Training Enhances Vision and Contrast Sensitivity in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:9.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

48. BEYDOUN MA, Beydoun HA, Manson JE, Tinker L, et al
    Body Mass Index-Specific Central Adiposity and Risk of Incident Type 2 Diabetes Among Aging Women.
    J Clin Endocrinol Metab. 2026 Oct 31:dgag443. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

49. ROY J, Jiang Y, Mao R, King JL, et al
    Synthetic immunological niche reveals early immune dysregulation and stratifies therapeutic response in type 1 diabetes.
    J Clin Invest. 2026 Nov 3:e206433. doi: 10.1172/JCI206433.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

50. NARUSE M, Kato H, Yamakage H, Tanaka M, et al
    Prevalence and associated factors of cognitive impairment and frailty in patients with type 2 diabetes and/or obesity: The Japan Diabetes and Obesity Study 3 (J-DOS3).
    J Diabetes Complications. 2026;41:109450.
    PubMed         Abstract available
    
    

    
    J Hypertens

51. HUML M, Kotkova A, Fremuthova T, Fiklik K, et al
    Continual cuffless blood pressure monitoring in children: agreement and feasibility compared with ambulatory blood pressure monitoring.
    J Hypertens. 2026;44:2067-2074.
    PubMed         Abstract available
    
    

    
    Metabolism

52. GONI L, Ruiz-Canela M
    Reply to "Oxidative balance metabolite signatures in PREDIMED: interpreting the divergent cardiovascular and diabetes findings".
    Metabolism. 2026 Nov 1:156815. doi: 10.1016/j.metabol.2026.156815.
    PubMed        
    
    

    
    Nature

53. WANG S, Berumen J, Vergara-Lope A, Baca P, et al
    Within-family effect of ancestry on complex traits in a Mexican population.
    Nature. 2026;659:133-140.
    PubMed         Abstract available
    
    

    
    Ophthalmology

54. WEI JC, Kao WC
    Re: Abdi et al.: Systemic Interleukin-6 Inhibition and Risk of Diabetic Retinopathy Development and Progression (Ophthalmology. 2026).
    Ophthalmology. 2026 Oct 31:S0161-6420(26)00770.
    PubMed        
    
    

    
    PLoS Med

55. TALL S, Turtinen M, Parviainen A, Pettersson J, et al
    Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study.
    PLoS Med. 2026;23:e1005288.
    PubMed         Abstract available
    
    

    
    PLoS One

56. NIAZ SMR, Jannat S, Al Ashik SA, Islam MK, et al
    Unveiling Molecular Basis of Terminalia chebula in Modulating the AGE-RAGE-PRKCB Axis in Diabetic Nephropathy: Integrative Network Pharmacology and Computational Study.
    PLoS One. 2026;21:e0362295.
    PubMed         Abstract available
    
    
57. LIU Y, Yu CX, Lu L
    Genotype-derived interpretive categories of drug response in 908 pharmacogenomic reports from Chinese patients with type 2 diabetes: A retrospective single-centre study.
    PLoS One. 2026;21:e0351903.
    PubMed         Abstract available
    
    
58. AYETEBE ABOGO MN, Guerrero Fernandez M, Ferrandiz Gomis R, Jimenez Fernandez R, et al
    Impact of cardiometabolic and renal phenotypes on the prevalence of type 2 diabetes in the geriatric population of Anisok, Equatorial Guinea: A prospective cohort study (2024-2025).
    PLoS One. 2026;21:e0360673.
    PubMed         Abstract available
    
    
59. JIANG Z, Qian W, Yang H, Luo Y, et al
    Development and internal validation of machine learning models for predicting prediabetes in China.
    PLoS One. 2026;21:e0361704.
    PubMed         Abstract available
    
    
60. AYLI BI, Ikhlef C, Gok Oguz E, Paksoy N, et al
    Diabetes and all-cause mortality in hemodialysis: A comparative survival analysis with complementary machine-learning methods.
    PLoS One. 2026;21:e0349639.
    PubMed         Abstract available
    
    
61. LIN Y, Ma Z, Zhang J, Zhuang J, et al
    Effects and mechanisms of exercise timing on cognitive function in older type 2 diabetes mellitus patients with mild cognitive impairment: A magnetic resonance imaging-based randomized controlled trial protocol.
    PLoS One. 2026;21:e0361868.
    PubMed         Abstract available
    
    
62. MUN Y, Shin YJ, Yi K, Choi DG, et al
    Cytokine profiles of aqueous humor from sequential bilateral cataract surgery: Impact of diabetes on inflammatory responses.
    PLoS One. 2026;21:e0361977.
    PubMed         Abstract available
    
    
63. SUN S, Yang G, Tong H, Zhao H, et al
    Online co-care management and glycemic control in patients with type 2 diabetes mellitus: A propensity score-matched retrospective cohort study.
    PLoS One. 2026;21:e0360677.
    PubMed         Abstract available
    
    
64. DAMAGUM FM, Hassan AH, Uloko AE, Habeeb HA, et al
    Female sexual dysfunction in premenopausal women with diabetes mellitus in northern Nigeria: A cross-sectional study from two tertiary hospitals examining associations with glycaemic control and reproductive hormones.
    PLoS One. 2026;21:e0361503.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

65. 
    Correction for Borowiec et al., Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction.
    Proc Natl Acad Sci U S A. 2026;123:e2636951123.
    PubMed        
    
    

    
    WMJ

66. NICKSIC VB, Beaton WN, Forbes GS, Cornelius AL, et al
    Diabetes Health Care Transition Assessment at School: Collaborating with School Nurses for Success.
    WMJ. 2026;125:506-508.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum